Show Notes
Do life-saving statins secretly damage your brain? This episode tackles the controversial link between statins and dementia head-on. I'll explore the origins of the fear, from patient anecdotes to plausible science, and weigh it against the highest-quality evidence from large clinical trials. We'll separate the myths from the facts to reach a clear, evidence-based verdict on how these drugs truly affect your brain.
Sign up for my free newsletter to receive analysis, reviews, and my interpretations of the most recent research to help you stay active for life.
Click Here: https://www.jrennickemd.com
CHAPTERS:
00:00 - Intro
01:07 - Where This Idea Came From
04:55 - The Possible Mechanism Cause of Symptoms
07:31 - The Scientific Evidence for Harm
11:20 - The Evidence Against The Claims
14:20 - Putting It All Together: A Unifying Framework
18:57 - Final Thoughts/ Guidance
23:32 - Outro
SELECTED REFERENCES:
https://pubmed.ncbi.nlm.nih.gov/12885101/
https://doi.org/10.4172/2329-6887.1000141
https://pmc.ncbi.nlm.nih.gov/articles/PMC5487843/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5487843/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5487843/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5487843/
https://www.jacc.org/doi/10.1016/j.jacc.2021.04.075
Disclaimer This podcast is for entertainment, education, and informational purposes only. The topics discussed should not solely be used to diagnose, treat , or prevent any condition. The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate. Always seek the advice of your personal physician or qualified health care provider for questions regarding any medical condition.
More from Building Lifelong Athletes
In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.
Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.
In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.
Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.